Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons From 2012-2017. Academic Article uri icon

Overview

abstract

  • Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.

publication date

  • August 1, 2021

Research

keywords

  • Surgeons

Identity

Scopus Document Identifier

  • 85114521869

Digital Object Identifier (DOI)

  • 10.36849/JDD.5909

PubMed ID

  • 34397191

Additional Document Info

volume

  • 20

issue

  • 8